Insmed, Inc. (INSM)
174.04
-0.05
(-0.03%)
USD |
NASDAQ |
Dec 31, 16:00
174.10
+0.06
(+0.03%)
After-Hours: 20:00
Insmed Free Cash Flow: -906.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Biogen, Inc. | 2.262B |
| Pfizer Inc. | 10.38B |
| Nektar Therapeutics | -190.35M |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -219.76M |
| Cash from Investing (Quarterly) | -762.23M |
| Cash from Financing (Quarterly) | 33.41M |
| Free Cash Flow Per Share (Quarterly) | -1.049 |
| Free Cash Flow to Equity (Quarterly) | -223.92M |
| Free Cash Flow to Firm (Quarterly) | -201.72M |
| Free Cash Flow Yield | -2.74% |